Literature DB >> 18707953

Delirium issues in palliative care settings.

Maeve Leonard1, Meera Agar, Colin Mason, Peter Lawlor.   

Abstract

OBJECTIVE: The objective of this study is to provide an expert review of delirium in the context of palliative care.
METHODS: Based on a primary selection criterion, firstly, studies were included for review if the population studied either had a diagnosis of advanced cancer or was receiving palliative care; alternatively, in the absence of data derived from these populations, studies conducted in other populations were included. Secondly, from the studies meeting the primary selection criterion, we selected those that examined specific standard outcome measures. Thirdly, we selected studies and literature reviews that identified delirium research issues.
RESULTS: Delirium occurs commonly in the context of palliative care where it is likely to cause heightened distress for patients, carers, and families alike, and make interpretation of pain and other symptoms extremely difficult. There is a profound dearth of rigorous studies on delirium in this setting. Ambiguous terminology, varying definitions in internationally recognized classification systems, and failure to use validated assessment tools lead to wide-ranging incidence and prevalence of delirium episodes in such populations. Episodes are usually multifactorial in origin and may portend poor prognosis by preceding death in many cases. Despite this, many are often at least partially reversible with relatively low-burden interventions. The patient's disease status, previous quality of life, and prior expressed wishes regarding goals of care should all be taken into account. Antipsychotics are the pharmacotherapeutic agents most commonly used to control symptoms despite limited evidence either supporting their efficacy or examining their adverse event profile. Often, symptomatic control alone is indicated. In cases with refractory symptoms, deeper or "palliative" sedation may be required.
CONCLUSION: Further research is needed regarding delirium recognition, phenomenology, the development of low-burden instruments for assessment, family education, predictive models for reversibility, and evidence-based guidelines on the appropriate use of palliative sedation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707953     DOI: 10.1016/j.jpsychores.2008.05.018

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  12 in total

Review 1.  Drug therapy optimization at the end of life.

Authors:  Alfonso J Cruz-Jentoft; Benoit Boland; Lourdes Rexach
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Management of delirium in palliative care: a review.

Authors:  Luigi Grassi; Augusto Caraceni; Alex J Mitchell; Maria Giulia Nanni; Maria Alejandra Berardi; Rosangela Caruso; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2015-03       Impact factor: 5.285

Review 3.  Prostate cancer: issues in psychosomatic medicine.

Authors:  Keira Chism; Elisabeth J S Kunkel
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

4.  Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.

Authors:  Gregory B Crawford; Meera Agar M; Stephen J Quinn; Jane Phillips; Caroline Litster; Natasha Michael; Matthew Doogue; Debra Rowett; David C Currow
Journal:  J Palliat Med       Date:  2013-10-18       Impact factor: 2.947

5.  Alternative forms of hydration in patients with cancer in the last days of life: study protocol for a randomised controlled trial.

Authors:  Andrew Davies; Melanie Waghorn; Julia Boyle; Ann Gallagher; Sigurd Johnsen
Journal:  Trials       Date:  2015-10-14       Impact factor: 2.279

6.  Developing guidelines on the assessment and treatment of delirium in older adults at the end of life.

Authors:  Susan Brajtman; David Wright; David B Hogan; Pierre Allard; Venera Bruto; Deborah Burne; Laura Gage; Pierre R Gagnon; Cheryl A Sadowski; Sherri Helsdingen; Kimberley Wilson
Journal:  Can Geriatr J       Date:  2011-07-07

Review 7.  Development of a set of process and structure indicators for palliative care: the Europall project.

Authors:  Kathrin Woitha; Karen Van Beek; Nisar Ahmed; Jeroen Hasselaar; Jean-Marc Mollard; Isabelle Colombet; Lukas Radbruch; Kris Vissers; Yvonne Engels
Journal:  BMC Health Serv Res       Date:  2012-11-02       Impact factor: 2.655

8.  The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.

Authors:  Shirley Harvey Bush; Nathalie Lacaze-Masmonteil; Marie Theresa McNamara-Kilian; Alistair Richard MacDonald; Sallyanne Tierney; Franco Momoli; Meera Agar; David Christopher Currow; Peter Gerard Lawlor
Journal:  Trials       Date:  2016-08-11       Impact factor: 2.279

Review 9.  The experiences of caregivers of patients with delirium, and their role in its management in palliative care settings: an integrative literature review.

Authors:  Anne M Finucane; Jean Lugton; Catriona Kennedy; Juliet A Spiller
Journal:  Psychooncology       Date:  2016-05-01       Impact factor: 3.894

10.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.